Advanced proteomics and AI reveal blood protein changes, offering insights into early Alzheimer's detection and differentiation from mild cognitive impairment.

In a recent study posted to the Preprints with The Lancet SSRN* server, a team of researchers in China developed a machine learning-based diagnostic tool to detect tuberculosis and drug-resistant ...

Accurately distinguishing renal cell carcinoma (RCC) from normal kidney tissue is critical for identifying positive surgical margins (PSMs) during partial and radical nephrectomy, which remains the ...

BOSTON--(BUSINESS WIRE)--908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, is showcasing the use of its ...

Clinical applications for mass spectrometry technology have exploded in recent years. Mass spectrometry analysis is often faster, cheaper, and more sensitive than other methods and is thus ideally ...

Mass spectrometry is the new genomics, and Tucson is the place to be for the emerging market. At least that’s what Nina Ossanna, vice president and co-founder of Pharos Diagnostics, thinks. Ossanna is ...

A new review highlights how machine learning is transforming the way scientists detect and measure organic pollutants in the ...

In her lab at the Jackson Laboratory (JAX), Kristen O’Connell wants to know what goes awry in the brains of people with Alzheimer’s disease. One step toward answering this question is comparing the ...

Performance of a Cell-Free DNA-Based Multi-cancer Detection Test in Individuals Presenting With Symptoms Suspicious for Cancers Accurately distinguishing renal cell carcinoma (RCC) from normal kidney ...